McElhaugh Michael J.
SEC CIK 1635326 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | Chief Business Off | 1.66M | — | $101.5K | 5 | 2023-02-01 | 2025-02-14 |
Most active insiders at ABUS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nguyen Tuan | CFO | — | — |
| 2 | Androski Lindsay | Pres, CEO, Dir | — | — |
| 3 | Sawhney Roger | Dir | — | — |
| 4 | Beardsley Robert A | Dir | — | — |
McElhaugh Michael J. made no open-market trades at ABUS in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-19 | 2025-02-14 | ABUS | Arbutus Biopharma Corp | McElhaugh Michael J. | CEO, Interim Pres, Dir | A - Grant | $0.00 | +177.0K | 1.66M | +12% | $0 |
| 2025-02-05 | 2025-02-04 | ABUS | Arbutus Biopharma Corp | McElhaugh Michael J. | CEO, Interim Pres, Dir | S - Sale | $3.28 | -23.8K | 1.48M | -2% | -$78.0K | |
| D | 2024-02-05 | 2024-02-01 | ABUS | Arbutus Biopharma Corp | McElhaugh Michael J. | CEO, Interim Pres, Dir | A - Grant | $0.00 | +123.8K | 1.51M | +9% | $0 |
| D | 2024-02-05 | 2024-02-02 | ABUS | Arbutus Biopharma Corp | McElhaugh Michael J. | CEO, Interim Pres, Dir | S - Sale | $2.31 | -10.2K | 1.50M | -0.7% | -$23.5K |
| D | 2023-02-03 | 2023-02-01 | ABUS | Arbutus Biopharma Corp | McElhaugh Michael J. | Chief Business Off | A - Grant | $0.00 | +83.7K | 1.39M | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations